Protalix Biotherapeutics, Inc.
PLX
Revenue
17.85M
▲2.19M▲14.01%
3 Months ChangeAssets
82.26M
▲3.78M▲4.81%
3 Months ChangeLiabilities
29.36M
▲773.00k▲2.70%
3 Months ChangeFree Cash Flow
-5.36M
▼-8.95M▼-249.42%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-25
Form 8-K
ID: 0001558370-24-013664
2024-08-14
Form 10-Q
ID: 0001558370-24-012134
2024-08-14
Form 8-K
ID: 0001558370-24-012133
2024-06-28
Form 8-K
ID: 0001558370-24-009567
2024-05-10
Form 10-Q
ID: 0001558370-24-007695
2024-05-10
Form 8-K
ID: 0001558370-24-007692
2024-03-14
Form 8-K
ID: 0001558370-24-003160
2023-12-26
Form 8-K
ID: 0001558370-23-020006
2023-11-06
Form 10-Q
ID: 0001558370-23-017664
2023-11-06
Form 8-K
ID: 0001558370-23-017657